Locations:
Search
Recommendations on identifying and managing neurodevelopmental and related challenges
Phase 2 trials investigate sitagliptin and methimazole as adjuvant therapies
Aim is for use with clinician oversight to make screening safer and more efficient
Planning continues with critical, patient-focused input from nursing teams
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Rapid innovation is shaping the deep brain stimulation landscape
Study shows short-term behavioral training can yield objective and subjective gains
How we’re efficiently educating patients and care partners about treatment goals, logistics, risks and benefits
An expert’s take on evolving challenges, treatments and responsibilities through early adulthood
Comorbidities and medical complexity underlie far more deaths than SUDEP does
Novel Cleveland Clinic project is fueled by a $1 million NIH grant
Advertisement
Advertisement